Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;41(5):1058-1069.
doi: 10.1111/liv.14769. Epub 2021 Jan 2.

The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria

Marcel Razpotnik  1 , Simona Bota  1 , Philipp Wimmer  2 , Michael Hackl  2 , Gerald Lesnik  3 , Hannes Alber  2 , Markus Peck-Radosavljevic  1
Affiliations

The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria

Marcel Razpotnik et al. Liver Int. 2021 May.

Abstract

Background and aims: Recently published criteria by 2019 Cirrhotic Cardiomyopathy Consortium set a lower threshold for reduced ejection fraction to diagnose systolic dysfunction in cirrhotic patients, and stress testing was replaced by echocardiography strain imaging. The criteria to diagnose diastolic dysfunction are in general concordant with the 2016 ASE/EACVI guidelines and differ considerably from the 2005 Montreal recommendations. We aimed to assess the prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria.

Methods: Cirrhotic patients without another structural heart disease, arterial hypertension, portal vein thrombosis, HCC outside Milan criteria and presence of TIPS were enrolled. Speckle-tracking echocardiography was performed by EACVI certified investigators.

Results: A total of 122 patients with cirrhosis fulfilled the inclusion criteria. Overall prevalence of cirrhotic cardiomyopathy was similar for 2005 Montreal and 2019 CCC: 67.2% vs 55.7% (P = .09); and significantly higher compared to 2009 ASE/EACVI criteria: 67.2% vs 35.2% (P < .0001) and 55.7% vs 35.2% (P = .002) respectively. Significantly more patients had diastolic dysfunction according to the 2005 Montreal compared to the 2009 ASE/EACVI and 2019 CCC criteria: 64.8% vs 32.8% (P < .0001) and 64.8% vs 7.4% (P < .0001). Systolic dysfunction was more frequently diagnosed according to 2019 CCC criteria compared to 2005 Montreal (53.3% vs 16.4%,P < .0001) or ASE/EACVI criteria (53.3% vs 4.9%,P < .0001).

Conclusion: Cirrhotic cardiomyopathy was present in around 60% of cirrhotic patients when applying the hepatological criteria. A considerably higher prevalence of systolic dysfunction according to the 2019 CCC criteria was observed. Long-term follow-up studies are needed to establish the validity of these criteria to predict clinically relevant outcomes.

Keywords: cirrhosis; cirrhotic cardiomyopathy; diagnostic criteria; prevalence; strain imaging.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804-2811.
    1. Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869-875.
    1. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med. 1989;151(5):530-535.
    1. Liu H, Lee SS. Predicting cardiovascular complications after liver transplantation: 007 to the rescue? Liver Transpl. 2011;17:7-9.
    1. Voiosu AM, Daha IC, Voiosu TA, et al. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients. Liver Int. 2015;35:2547-2555.

Publication types

LinkOut - more resources